Download PDF
Semin Respir Crit Care Med 2006; 27(5): 508-520
DOI: 10.1055/s-2006-954611
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Medical Complications after Lung Transplantation

Selim M. Arcasoy1 , 2 , Jessie Wilt1 , 2
  • 1Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, New York, New York
  • 2Lung Transplantation Program, New York Presbyterian Hospital of Columbia and Cornell University, New York, New York
Further Information

Publication History

Publication Date:
26 October 2006 (online)

    Permissions and Reprints

ABSTRACT

Despite remarkable progress in short-term functional and survival outcomes following lung transplantation, long-term outcomes remain limited due to a multitude of medical complications caused predominantly by immunosuppressive protocols. Although chronic allograft rejection and infection account for the majority of deaths beyond the first year after lung transplantation, a large number of other medical problems contribute significantly to excess mortality and morbidity. This article reviews the most frequent and important medical complications of lung transplantation, other than rejection and infection, with an emphasis on complications that involve the respiratory tract.

KEYWORDS

Lung transplantation - complications - posttransplant malignancy - venous thromboembolism - immunosuppression

REFERENCES

  • 1 Reitz B A, Wallwork J L, Hunt S A et al.. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease.  N Engl J Med. 1982;  306 557-564
    CrossrefPubMedGoogle Scholar
  • 2 Trulock E P, Edwards L B, Taylor D O, Boucek M M, Keck B M, Hertz M I. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005.  J Heart Lung Transplant. 2005;  24 956-967
    CrossrefPubMedGoogle Scholar
  • 3 Arcasoy S M. Medical complications and management of lung transplant recipients.  Respir Care Clin N Am. 2004;  10 505-529
    PubMedGoogle Scholar
  • 4 Konen E, Weisbrod G L, Pakhale S, Chung T, Paul N S, Hutcheon M A. Fibrosis of the upper lobes: a newly identified late-onset complication after lung transplantation?.  AJR Am J Roentgenol. 2003;  181 1539-1543
    PubMedGoogle Scholar
  • 5 Pakhale S S, Hadjiliadis D, Howell D N et al.. Upper lobe fibrosis: a novel manifestation of chronic allograft dysfunction in lung transplantation.  J Heart Lung Transplant. 2005;  24 1260-1268
    PubMedGoogle Scholar
  • 6 Collins J, Hartman M J, Warner T F et al.. Frequency and CT findings of recurrent disease after lung transplantation.  Radiology. 2001;  219 503-509
    CrossrefPubMedGoogle Scholar
  • 7 Kazerooni E A, Cascade P N. Recurrent miliary sarcoidosis after lung transplantation.  Radiology. 1995;  194 913
    PubMedGoogle Scholar
  • 8 Kazerooni E A, Jackson C, Cascade P N. Sarcoidosis: recurrence of primary disease in transplanted lungs.  Radiology. 1994;  192 461-464
    CrossrefPubMedGoogle Scholar
  • 9 Yeatman M, McNeil K, Smith J A et al.. Lung transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital.  J Heart Lung Transplant. 1996;  15 144-149
    PubMedGoogle Scholar
  • 10 Johnson B A, Duncan S R, Ohori N P et al.. Recurrence of sarcoidosis in pulmonary allograft recipients.  Am Rev Respir Dis. 1993;  148 1373-1377
    CrossrefPubMedGoogle Scholar
  • 11 Bjortuft O, Foerster A, Boe J, Geiran O. Single-lung transplantation as treatment for end-stage pulmonary sarcoidosis: recurrence of sarcoidosis in two different lung allografts in one patient.  J Heart Lung Transplant. 1994;  13 24-29
    PubMedGoogle Scholar
  • 12 Carre P, Rouquette I, Durand D et al.. Recurrence of sarcoidosis in a human lung allograft.  Transplant Proc. 1995;  27 1686
    PubMedGoogle Scholar
  • 13 Martinez F J, Orens J B, Deeb M, Brunsting L A, Flint A, Lynch III J P. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation.  Chest. 1994;  106 1597-1599
    CrossrefPubMedGoogle Scholar
  • 14 Muller C, Briegel J, Haller M et al.. Sarcoidosis recurrence following lung transplantation.  Transplantation. 1996;  61 1117-1119
    PubMedGoogle Scholar
  • 15 Etienne B, Bertocchi M, Gamondes J P et al.. Relapsing pulmonary Langerhans' cell histiocytosis after lung transplantation.  Am J Respir Crit Care Med. 1998;  157 288-291
    CrossrefPubMedGoogle Scholar
  • 16 Gabbay E, Dark J H, Ashcroft T et al.. Recurrence of Langerhans' cell granulomatosis following lung transplantation.  Thorax. 1998;  53 326-327
    CrossrefPubMedGoogle Scholar
  • 17 Habib S B, Congleton J, Carr D et al.. Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation.  Thorax. 1998;  53 323-325
    CrossrefPubMedGoogle Scholar
  • 18 Dauriat G, Mal H, Thabut G et al.. Lung transplantation for pulmonary Langerhans' cell histiocytosis: a multicenter analysis.  Transplantation. 2006;  81 746-750
    CrossrefPubMedGoogle Scholar
  • 19 O'Brien J D, Lium J H, Parosa J F, Deyoung B R, Wick M R, Trulock E P. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation.  Am J Respir Crit Care Med. 1995;  151 2033-2036
    PubMedGoogle Scholar
  • 20 Bittmann I, Dose T B, Muller C, Dienemann H, Vogelmeier C, Lohrs U. Lymphangioleiomyomatosis: recurrence after single lung transplantation.  Hum Pathol. 1997;  28 1420-1423
    CrossrefPubMedGoogle Scholar
  • 21 Boehler A, Speich R, Russi E W, Weder W. Lung transplantation for lymphangioleiomyomatosis.  N Engl J Med. 1996;  335 1275-1280
    CrossrefPubMedGoogle Scholar
  • 22 Nine J S, Yousem S A, Paradis I L, Keenan R, Griffith B P. Lymphangioleiomyomatosis: recurrence after lung transplantation.  J Heart Lung Transplant. 1994;  13 714-719
    PubMedGoogle Scholar
  • 23 Garver Jr R I, Zorn G L, Wu X, McGiffin D C, Young Jr K R, Pinkard N B. Recurrence of bronchioloalveolar carcinoma in transplanted lungs.  N Engl J Med. 1999;  340 1071-1074
    CrossrefPubMedGoogle Scholar
  • 24 de Perrot M, Chernenko S, Waddell T K et al.. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease.  J Clin Oncol. 2004;  22 4351-4356
    CrossrefPubMedGoogle Scholar
  • 25 Baz M A, Kussin P S, Van Trigt P, Davis R D, Roggli V L, Tapson V F. Recurrence of diffuse panbronchiolitis after lung transplantation.  Am J Respir Crit Care Med. 1995;  151 895-898
    PubMedGoogle Scholar
  • 26 King M B, Jessurun J, Hertz M I. Recurrence of desquamative interstitial pneumonia after lung transplantation.  Am J Respir Crit Care Med. 1997;  156 2003-2005
    PubMedGoogle Scholar
  • 27 Frost A E, Keller C A, Brown R W et al.. Giant cell interstitial pneumonitis: disease recurrence in the transplanted lung.  Am Rev Respir Dis. 1993;  148 1401-1404
    PubMedGoogle Scholar
  • 28 Calabrese F, Giacometti C, Rea F et al.. Recurrence of idiopathic pulmonary hemosiderosis in a young adult patient after bilateral single-lung transplantation.  Transplantation. 2002;  74 1643-1645
    PubMedGoogle Scholar
  • 29 Cook R C, Fradet G, English J C et al.. Recurrence of intravenous talc granulomatosis following single lung transplantation.  Can Respir J. 1998;  5 511-514
    PubMedGoogle Scholar
  • 30 Parker L A, Novotny D B. Recurrent alveolar proteinosis following double lung transplantation.  Chest. 1997;  111 1457-1458
    PubMedGoogle Scholar
  • 31 Stewart S, McNeil K, Nashef S A, Wells F C, Higenbottam T W, Wallwork J. Audit of referral and explant diagnoses in lung transplantation: a pathologic study of lungs removed for parenchymal disease.  J Heart Lung Transplant. 1995;  14 1173-1186
    PubMedGoogle Scholar
  • 32 Mal H, Guignabert C, Thabut G et al.. Recurrence of pulmonary emphysema in an alpha-1 proteinase inhibitor-deficient lung transplant recipient.  Am J Respir Crit Care Med. 2004;  170 811-814
    CrossrefPubMedGoogle Scholar
  • 33 Buell J F, Gross T G, Woodle E S. Malignancy after transplantation.  Transplantation. 2005;  80 S254-S264
    CrossrefPubMedGoogle Scholar
  • 34 Maurer J M, Frost A E, Glanville A R, Estenne M, Higenbottam T. International Guidelines for the Selection of Lung Transplant Candidates.  Am J Respir Crit Care Med. 1998;  158 335-339
    PubMedGoogle Scholar
  • 35 Levine S M. A survey of clinical practice of lung transplantation in North America.  Chest. 2004;  125 1224-1238
    CrossrefPubMedGoogle Scholar
  • 36 Cohen J I. Epstein-Barr virus infection.  N Engl J Med. 2000;  343 481-492
    CrossrefPubMedGoogle Scholar
  • 37 Bakker N A, van Imhoff G W, Verschuuren E A et al.. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.  Clin Transplant. 2005;  19 327-334
    CrossrefPubMedGoogle Scholar
  • 38 Ramalingam P, Rybicki L, Smith M D et al.. Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience.  Mod Pathol. 2002;  15 647-656
    CrossrefPubMedGoogle Scholar
  • 39 Reams B D, McAdams H P, Howell D N, Steele M P, Davis R D, Palmer S M. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.  Chest. 2003;  124 1242-1249
    CrossrefPubMedGoogle Scholar
  • 40 Gao S Z, Chaparro S V, Perlroth M et al.. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.  J Heart Lung Transplant. 2003;  22 505-514
    CrossrefPubMedGoogle Scholar
  • 41 Benden C, Aurora P, Burch M et al.. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.  J Heart Lung Transplant. 2005;  24 2103-2108
    PubMedGoogle Scholar
  • 42 Leung E, Shenton B K, Green K et al.. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.  Transpl Infect Dis. 2004;  6 156-164
    CrossrefPubMedGoogle Scholar
  • 43 Marom E M, McAdams H P, Butnor K J, Coleman R E. Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients.  J Thorac Imaging. 2004;  19 74-78
    CrossrefPubMedGoogle Scholar
  • 44 Wigle D A, Chaparro C, Humar A, Hutcheon M A, Chan C K, Keshavjee S. Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation.  Transplantation. 2001;  72 1783-1786
    CrossrefPubMedGoogle Scholar
  • 45 Paranjothi S, Yusen R D, Kraus M D, Lynch J P, Patterson G A, Trulock E P. Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases.  J Heart Lung Transplant. 2001;  20 1054-1063
    CrossrefPubMedGoogle Scholar
  • 46 Hachem R R, Chakinala M M, Yusen R D et al.. Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.  Transplantation. 2004;  77 431-437
    CrossrefPubMedGoogle Scholar
  • 47 Tsai D E, Hardy C L, Tomaszewski J E et al.. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients.  Transplantation. 2001;  71 1076-1088
    PubMedGoogle Scholar
  • 48 Malouf M A, Chhajed P N, Hopkins P, Plit M, Turner J, Glanville A R. Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.  J Heart Lung Transplant. 2002;  21 547-554
    CrossrefPubMedGoogle Scholar
  • 49 Knoop C, Kentos A, Remmelink M et al.. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.  Clin Transplant. 2006;  20 179-187
    CrossrefPubMedGoogle Scholar
  • 50 Oertel S H, Verschuuren E, Reinke P et al.. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).  Am J Transplant. 2005;  5 2901-2906
    CrossrefPubMedGoogle Scholar
  • 51 Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. a population-based cohort study.  Am J Respir Crit Care Med. 2000;  161 5-8
    PubMedGoogle Scholar
  • 52 Arcasoy S M, Hersh C, Christie J D et al.. Bronchogenic carcinoma complicating lung transplantation.  J Heart Lung Transplant. 2001;  20 1044-1053
    CrossrefPubMedGoogle Scholar
  • 53 Collins J, Kazerooni E A, Lacomis J et al.. Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings.  Radiology. 2002;  224 131-138
    CrossrefPubMedGoogle Scholar
  • 54 Abrahams N A, Meziane M, Ramalingam P, Mehta A, DeCamp M, Farver C F. Incidence of primary neoplasms in explanted lungs: long-term follow-up from 214 lung transplant patients.  Transplant Proc. 2004;  36 2808-2811
    CrossrefPubMedGoogle Scholar
  • 55 Lee P, Minai O A, Mehta A C, DeCamp M M, Murthy S. Pulmonary nodules in lung transplant recipients: etiology and outcome.  Chest. 2004;  125 165-172
    CrossrefPubMedGoogle Scholar
  • 56 Ferrer J, Roldan J, Roman A et al.. Acute and chronic pleural complications in lung transplantation.  J Heart Lung Transplant. 2003;  22 1217-1225
    CrossrefPubMedGoogle Scholar
  • 57 Herridge M S, de Hoyos A L, Chaparro C, Winton T L, Kesten S, Maurer J R. Pleural complications in lung transplant recipients.  J Thorac Cardiovasc Surg. 1995;  110 22-26
    PubMedGoogle Scholar
  • 58 Judson M A, Handy J R, Sahn S A. Pleural effusions following lung transplantation: time course, characteristics, and clinical implications.  Chest. 1996;  109 1190-1194
    CrossrefPubMedGoogle Scholar
  • 59 Judson M A, Handy J R, Sahn S A. Pleural effusion from acute lung rejection.  Chest. 1997;  111 1128-1130
    PubMedGoogle Scholar
  • 60 Kroshus T J, Kshettry V R, Hertz M I, Bolman III R M. Deep venous thrombosis and pulmonary embolism after lung transplantation.  J Thorac Cardiovasc Surg. 1995;  110 540-544
    PubMedGoogle Scholar
  • 61 Nathan S D, Barnett S D, Urban B A, Nowalk C, Moran B R, Burton N. Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients.  Chest. 2003;  123 1758-1763
    CrossrefPubMedGoogle Scholar
  • 62 Jankowich M D. Idiopathic pulmonary fibrosis in transplantation.  Chest. 2003;  124 2404 , author reply 2404-2405
    CrossrefPubMedGoogle Scholar
  • 63 Burns K E, Iacono A T. Incidence of clinically unsuspected pulmonary embolism in mechanically ventilated lung transplant recipients.  Transplantation. 2003;  76 964-968
    PubMedGoogle Scholar
  • 64 Burns K E, Iacono A T. Pulmonary embolism on postmortem examination: an under-recognized complication in lung-transplant recipients?.  Transplantation. 2004;  77 692-698
    PubMedGoogle Scholar
  • 65 Yegen H A, Lederer D J, Wilt J S et al.. Risk factors for venous thromboembolism in lung transplant recipient [abstract].  Am J Respir Crit Care Med. 2006;  3 A536
    PubMedGoogle Scholar
  • 66 Hammoud D, Chin B. False-positive ventilation-perfusion scan in a patient with a transplanted lung.  Clin Nucl Med. 2003;  28 472-475
    CrossrefPubMedGoogle Scholar
  • 67 King-Biggs M B, Dunitz J M, Park S J, Kay Savik S, Hertz M I. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation.  Transplantation. 2003;  75 1437-1443
    CrossrefPubMedGoogle Scholar
  • 68 Groetzner J, Kur F, Spelsberg F et al.. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression.  J Heart Lung Transplant. 2004;  23 632-638
    CrossrefPubMedGoogle Scholar
  • 69 Vlahakis N E, Rickman O B, Morgenthaler T. Sirolimus-associated diffuse alveolar hemorrhage.  Mayo Clin Proc. 2004;  79 541-545
    PubMedGoogle Scholar
  • 70 Morelon E, Stern M, Israel-Biet D et al.. Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients.  Transplantation. 2001;  72 787-790
    CrossrefPubMedGoogle Scholar
  • 71 Morelon E, Stern M, Kreis H. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients.  N Engl J Med. 2000;  343 225-226
    CrossrefPubMedGoogle Scholar
  • 72 McWilliams T J, Levvey B J, Russell P A, Milne D G, Snell G I. Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation.  J Heart Lung Transplant. 2003;  22 210-213
    CrossrefPubMedGoogle Scholar
  • 73 Champion L, Stern M, Israel-Biet D et al.. Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients.  Ann Intern Med. 2006;  144 505-509
    PubMedGoogle Scholar
  • 74 Lindenfeld J A, Simon S F, Zamora M R et al.. BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus.  Am J Transplant. 2005;  5 1392-1396
    CrossrefPubMedGoogle Scholar
  • 75 Garrean S, Massad M G, Tshibaka M, Hanhan Z, Caines A E, Benedetti E. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.  Clin Transplant. 2005;  19 698-703
    CrossrefPubMedGoogle Scholar
  • 76 Manito N, Kaplinsky E J, Bernat R et al.. Fatal interstitial pneumonitis associated with sirolimus therapy in a heart transplant recipient.  J Heart Lung Transplant. 2004;  23 780-782
    PubMedGoogle Scholar
  • 77 Mal H, Brugiere O, Sleiman C et al.. Morbidity and mortality related to the native lung in single lung transplantation for emphysema.  J Heart Lung Transplant. 2000;  19 220-223
    CrossrefPubMedGoogle Scholar
  • 78 McAdams H P, Erasmus J J, Palmer S M. Complications (excluding hyperinflation) involving the native lung after single-lung transplantation: incidence, radiologic features, and clinical importance.  Radiology. 2001;  218 233-241
    PubMedGoogle Scholar
  • 79 Speziali G, McDougall J C, Midthun D E et al.. Native lung complications after single lung transplantation for emphysema.  Transpl Int. 1997;  10 113-115
    CrossrefPubMedGoogle Scholar
  • 80 Venuta F, Boehler A, Rendina E A et al.. Complications in the native lung after single lung transplantation.  Eur J Cardiothorac Surg. 1999;  16 54-58
    CrossrefPubMedGoogle Scholar
  • 81 Frost A E, Keller C A, Noon G P, Short H D, Cagle P T. Outcome of the native lung after single lung transplant. Multiorgan Transplant Group.  Chest. 1995;  107 981-984
    CrossrefPubMedGoogle Scholar
  • 82 Yonan N A, el-Gamel A, Egan J, Kakadellis J, Rahman A, Deiraniya A K. Single lung transplantation for emphysema: predictors for native lung hyperinflation.  J Heart Lung Transplant. 1998;  17 192-201
    PubMedGoogle Scholar
  • 83 Weill D, Torres F, Hodges T N, Olmos J J, Zamora M R. Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema.  J Heart Lung Transplant. 1999;  18 1080-1087
    CrossrefPubMedGoogle Scholar
  • 84 Moy M L, Loring S H, Ingenito E P, Mentzer S J, Reilly Jr J J. Causes of allograft dysfunction after single lung transplantation for emphysema: extrinsic restriction versus intrinsic obstruction. Brigham and Women's Hospital Lung Transplantation Group.  J Heart Lung Transplant. 1999;  18 986-993
    PubMedGoogle Scholar
  • 85 Anderson M B, Kriett J M, Kapelanski D P, Perricone A, Smith C M, Jamieson S W. Volume reduction surgery in the native lung after single lung transplantation for emphysema.  J Heart Lung Transplant. 1997;  16 752-757
    PubMedGoogle Scholar
  • 86 Schulman L L, O'Hair D P, Cantu E, McGregor C, Ginsberg M E. Salvage by volume reduction of chronic allograft rejection in emphysema.  J Heart Lung Transplant. 1999;  18 107-112
    CrossrefPubMedGoogle Scholar
  • 87 Venuta F, De Giacomo T, Rendina E A et al.. Thoracoscopic volume reduction of the native lung after single lung transplantation for emphysema.  Am J Respir Crit Care Med. 1998;  157 292-293
    PubMedGoogle Scholar
  • 88 Kotloff R M, Ahya V N. Medical complications of lung transplantation.  Eur Respir J. 2004;  23 334-342
    CrossrefPubMedGoogle Scholar
  • 89 Verleden G M, Besse T, Maes B. Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient.  Transplantation. 2002;  73 1974-1976
    PubMedGoogle Scholar
  • 90 Weinkauf J G, Yiannopoulos A, Faul J L. Transcutaneous electrical nerve stimulation for severe gastroparesis after lung transplantation.  J Heart Lung Transplant. 2005;  24 1444.e1-1444.e3
    PubMedGoogle Scholar
  • 91 Yiannopoulos A, Shafazand S, Ziedalski T et al.. Gastric pacing for severe gastroparesis in a heart-lung transplant recipient.  J Heart Lung Transplant. 2004;  23 371-374
    PubMedGoogle Scholar
  • 92 Young L R, Hadjiliadis D, Davis R D, Palmer S M. Lung transplantation exacerbates gastroesophageal reflux disease.  Chest. 2003;  124 1689-1693
    CrossrefPubMedGoogle Scholar
  • 93 D'Ovidio F, Singer L G, Hadjiliadis D et al.. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant.  Ann Thorac Surg. 2005;  80 1254-1260
    CrossrefPubMedGoogle Scholar
  • 94 D'Ovidio F, Mura M, Tsang M et al.. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.  J Thorac Cardiovasc Surg. 2005;  129 1144-1152
    CrossrefPubMedGoogle Scholar
  • 95 Hadjiliadis D, Duane Davis R, Steele M P et al.. Gastroesophageal reflux disease in lung transplant recipients.  Clin Transplant. 2003;  17 363-368
    CrossrefPubMedGoogle Scholar
  • 96 Palmer S M, Miralles A P, Howell D N, Brazer S R, Tapson V F, Davis R D. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation.  Chest. 2000;  118 1214-1217
    CrossrefPubMedGoogle Scholar
  • 97 Davis Jr R D, Lau C L, Eubanks S et al.. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.  J Thorac Cardiovasc Surg. 2003;  125 533-542
    CrossrefPubMedGoogle Scholar
  • 98 Smith P C, Slaughter M S, Petty M G, Shumway S J, Kshettry V R, Bolman III R M. Abdominal complications after lung transplantation.  J Heart Lung Transplant. 1995;  14 44-51
    PubMedGoogle Scholar
  • 99 Gilljam M, Chaparro C, Tullis E, Chan C, Keshavjee S, Hutcheon M. GI complications after lung transplantation in patients with cystic fibrosis.  Chest. 2003;  123 37-41
    CrossrefPubMedGoogle Scholar
  • 100 Hoekstra H J, Hawkins K, de Boer W J, Rottier K, van der Bij W. Gastrointestinal complications in lung transplant survivors that require surgical intervention.  Br J Surg. 2001;  88 433-438
    CrossrefPubMedGoogle Scholar
  • 101 Lubetkin E I, Lipson D A, Palevsky H I et al.. GI complications after orthotopic lung transplantation.  Am J Gastroenterol. 1996;  91 2382-2390
    PubMedGoogle Scholar
  • 102 Dellon E S, Morgan D R, Mohanty S P, Davis K, Aris R M. High incidence of gastric bezoars in cystic fibrosis patients after lung transplantation.  Transplantation. 2006;  81 1141-1146
    CrossrefPubMedGoogle Scholar
  • 103 Hachem R R, Chakinala M M, Yusen R D et al.. Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.  Transplantation. 2004;  77 431-437
    CrossrefPubMedGoogle Scholar
  • 104 Calvet A, Pujol M O, Bertocchi M, Bastien O, Boissonnat P, Mornex J F. Parvovirus B19 infection in thoracic organ transplant recipients.  J Clin Virol. 1999;  13 37-42
    CrossrefPubMedGoogle Scholar
  • 105 Kariyawasam H H, Gyi K M, Hodson M E, Cohen B J. Anaemia in lung transplant patient caused by parvovirus B19.  Thorax. 2000;  55 619-620
    CrossrefPubMedGoogle Scholar
  • 106 Salerno C T, Burdine J, Perry E H, Kshettry V R, Hertz M I, Bolman III R M. Donor-derived antibodies and hemolysis after ABO-compatible but nonidentical heart-lung and lung transplantation.  Transplantation. 1998;  65 261-264
    PubMedGoogle Scholar
  • 107 Taaning E, Morling N, Mortensen S A, Pettersson G, Simonsen A C. Severe hemolysis caused by graft-derived anti-B production after lung transplantation.  J Heart Lung Transplant. 1996;  15 850-851
    PubMedGoogle Scholar
  • 108 Qu L, Kiss J E. Thrombotic microangiopathy in transplantation and malignancy.  Semin Thromb Hemost. 2005;  31 691-699
    Article in Thieme ConnectPubMedGoogle Scholar
  • 109 Hachem R R, Yusen R D, Chakinala M M, Aloush A A, Patterson G A, Trulock E P. Thrombotic microangiopathy after lung transplantation.  Transplantation. 2006;  81 57-63
    CrossrefPubMedGoogle Scholar
  • 110 Goldfarb N S, Avery R K, Goormastic M et al.. Hypogammaglobulinemia in lung transplant recipients.  Transplantation. 2001;  71 242-246
    CrossrefPubMedGoogle Scholar
  • 111 Kawut S M, Shah L, Wilt J S et al.. Risk factors and outcomes of hypogammaglobulinemia after lung transplantation.  Transplantation. 2005;  79 1723-1726
    CrossrefPubMedGoogle Scholar
  • 112 Yip N H, Lederer D J, Kawut S M et al.. Immunoglobulin G levels before and after lung transplantation.  Am J Respir Crit Care Med. 2006;  173 917-921
    CrossrefPubMedGoogle Scholar
  • 113 Rocha P N, Rocha A T, Palmer S M, Davis R D, Smith S R. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality.  Am J Transplant. 2005;  5 1469-1476
    CrossrefPubMedGoogle Scholar
  • 114 Ishani A, Erturk S, Hertz M I, Matas A J, Savik K, Rosenberg M E. Predictors of renal function following lung or heart-lung transplantation.  Kidney Int. 2002;  61 2228-2234
    CrossrefPubMedGoogle Scholar
  • 115 Venuta F, De Giacomo T, Rendina E A et al.. Recovery of chronic renal impairment with sirolimus after lung transplantation.  Ann Thorac Surg. 2004;  78 1940-1943
    CrossrefPubMedGoogle Scholar
  • 116 Shitrit D, Rahamimov R, Gidon S et al.. Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: results of a controlled pilot study.  Kidney Int. 2005;  67 1471-1475
    CrossrefPubMedGoogle Scholar
  • 117 Chobanian A V, Bakris G L, Black H R et al.. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  Hypertension. 2003;  42 1206-1252
    CrossrefPubMedGoogle Scholar
  • 118 Fletcher B, Berra K, Ades P et al.. Managing abnormal blood lipids: a collaborative approach.  Circulation. 2005;  112 3184-3209
    CrossrefPubMedGoogle Scholar
  • 119 Johnson B A, Iacono A T, Zeevi A, McCurry K R, Duncan S R. Statin use is associated with improved function and survival of lung allografts.  Am J Respir Crit Care Med. 2003;  167 1271-1278
    CrossrefPubMedGoogle Scholar

Selim M ArcasoyM.D. 

Columbia University College of Physicians and Surgeons, Lung Transplant Program

PH-14 East, Rm. 104, 622 W. 168th St., New York, NY 10032

Email: sa2059@columbia.edu

      >